Information about atrial fibrillation for healthcare and other professionals.
Stroke survivor and volunteer Emma Day shares her story and why volunteering is important.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
Browse through a list of organisations that can provide support and information about reducing the risk of stroke.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
People with a type of irregular heartbeat called atrial fibrillation (AF) are five times more likely to have a stroke. This guide explains what AF is diagnosed, how it increases your risk of stroke and how it is treated.
Atrial fibrillation is a type of irregular heartbeat that can cause blood clots to form in your heart. Having atrial fibrillation increases your risk of stroke by five times.
This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initation could lead to fewer recurrent strokes.
On 12 February 2015, at the International Stroke Conference (ISC 2015) in Nashville, USA, the findings of a Stroke Association funded study were presented, called CADISS (Cervical Artery Dissection In Stroke Study.
You might be prescribed blood-thinning medication to reduce your risk of a TIA or stroke. This guide explains the two types of blood-thinning medication available, antiplatelets and anticoagulants, and how they are used after a stroke or for someone with atrial fibrillation.